Molecular and cellular mechanisms of chemoresistance in pancreatic cancer

QR Code

Molecular and cellular mechanisms of chemoresistance in pancreatic cancer

Pancreatic Ductal Adenocarcinoma (PDAC) is one of the most chemoresistant cancers, and current therapies targeting cancer-associated molecular pathways have not given satisfactory results, owing in part to rapid upregulation of alternative compensatory pathways. Most of the available treatments are...

Full description

Bibliographic Details
Main Authors:	Adamska, Aleksandra, Elaskalani, Omar, Emmanouilidi, Aikaterini, Kim, Minkypung, Abdol Razak, Norbaini Binti, Metharom, Pat, Falasca, Marco
Format:	Journal Article
Published:	2018
Online Access:	http://hdl.handle.net/20.500.11937/62659

Similar Items

Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer
by: Elaskalani, O., et al.
Published: (2017)

Investigation of Novel Biomarkers for Pancreatic Cancer
by: Emmanouilidi, Aikaterini
Published: (2019)

The role of platelet-derived ADP and ATP in promoting pancreatic cancer cell survival and gemcitabine resistance
by: Elaskalani, Omar, et al.
Published: (2017)

Pancreatic cancer-induced neutrophil extracellular traps: A potential contributor to cancer-associated thrombosis
by: Razak, N., et al.
Published: (2017)

ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance.
by: Begicevic, R., et al.
Published: (2017)

ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: What is the way forward?
by: Adamska, A., et al.
Published: (2018)

Targeting platelets for the treatment of cancer
by: Elaskalani, Omar, et al.
Published: (2017)

Pancreatic ductal adenocarcinoma: Current and evolving therapies
by: Adamska, A., et al.
Published: (2017)

Diet and pancreatic cancer prevention
by: Casari, I., et al.
Published: (2015)

Pancreatic cancer: Current research and future directions
by: Falasca, Marco, et al.
Published: (2016)

Colon cancer chemoresistance and chemosensitization
by: Shanmugam, M., et al.
Published: (2018)

Targeting PDK1 for Chemosensitization of Cancer Cells.
by: Emmanouilidi, A., et al.
Published: (2017)

Emerging role of the KRAS-PDK1 axis in pancreatic cancer
by: Ferro, R., et al.
Published: (2014)

Neutrophil extracellular traps induce aggregation of washed human platelets independently of extracellular DNA and histones
by: Elaskalani, O., et al.
Published: (2018)

Mechanisms of Cancer-Associated Thrombosis: Role of Cancer-Derived Exosomes
by: Abdol Razak, Norbaini Binti
Published: (2024)

Targeting phosphoinositide 3-kinase pathways in pancreatic cancer - from molecular signalling to clinical trials
by: Falasca, Marco, et al.
Published: (2011)

ABC transporters and G protein-coupled receptors: perspectives for novel anti-cancer drugs
by: Adamska, Aleksandra
Published: (2019)

ABC transporters as cancer drivers: Potential functions in cancer development
by: Domenichini, Alice, et al.
Published: (2019)

Extracellular DNA and histones are dispensable for neutrophil extracellular trap-induced aggregation of human washed platelets
by: Elaskalani, O., et al.
Published: (2018)

The History of Armand Trousseau and Cancer-Associated Thrombosis
by: Metharom, Pat, et al.
Published: (2019)

Aging and cancer: The role of macrophages and neutrophils
by: Jackaman, Connie, et al.
Published: (2017)

Genomic analyses identify molecular subtypes of pancreatic cancer
by: Bailey, P., et al.
Published: (2016)

Dysregulation of Nrf2 in hepatocellular carcinoma: Role in cancer progression and chemoresistance
by: Raghunath, A., et al.
Published: (2018)

Characterization and chemoresistance of HT29 (Colon cancer) and TW06 (Nasopharyngeal cancer) tumorspheres
by: Goh, Iris Wen Li
Published: (2014)

GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine
by: Ferro, Riccardo, et al.
Published: (2018)

Key role of phosphoinositide 3-kinase class IB in pancreatic cancer
by: Edling, C., et al.
Published: (2010)

Regulation and cellular functions of class II phosphoinositide 3-kinases
by: Falasca, Marco, et al.
Published: (2012)

Hypermutation In Pancreatic Cancer
by: Humphris, J., et al.
Published: (2017)

Identification and molecular analysis of pancreatic cancer-derived small extracellular vesicles
by: Panda, Arunima
Published: (2024)

Investigating the mechanisms of activation and action of phosphoinositide 3-kinase C2 alpha in pancreatic beta cells
by: Mazza, S., et al.
Published: (2013)

GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine
by: Ferro, R., et al.
Published: (2018)

The role of phospholipase Cγ1 in breast cancer and its clinical significance
by: Emmanouilidi, A., et al.
Published: (2017)

Chemoresistance in breast cancer: PI3K/Akt pathway inhibitors vs the current chemotherapy
by: Kaboli, Parham Jabbarzadeh, et al.
Published: (2021)

Preoperative drainage in pancreatic cancer
by: Kennedy, Eugene P, et al.
Published: (2010)

The role of G protein-coupled receptor 35 in pancreatic cancer
by: Kim, Minkyoung
Published: (2020)

Cutting-edge biotechnological advancement in islet delivery using pancreatic and cellular approaches.
by: Elnashar, Magdy, et al.
Published: (2020)

Combatting chemoresistance: an analysis of DNA repair proteins ERCC1 and XPF and their chemotherapeutic implications in ovarian cancer
by: Griffin, Michaela
Published: (2019)

Expression of the Coxsackie and Adenovirus Receptor (CAR) in pancreatic cancer and normal pancreatic tissue
by: Verbeke, C. S., et al.
Published: (2006)

Targeting thioredoxin reductase in pancreatic cancer
by: Alhadyan, Khaled
Published: (2019)

Exploring the role of multidrug exporters and extracellular vesicles in medulloblastoma chemoresistance
by: Wade, Philippa
Published: (2024)